Clinical Trials on Bladder Cancer Recurrent in Belgium

Total 1861 results

Universitaire Ziekenhuizen KU Leuven

Completed

Gene Polymorphisms and Gene Products as Biological Markers of Aging and Correlation With Clinical Geriatric Assessment, Tolerance of Chemotherapy and Outcome in Elderly Breast Cancer Patients (EBS)

Breast Cancer | Elderly

Belgium
Centre Hospitalier Universitaire de Liege

Recruiting

Oral Immunonutrition With Synbiotics, Omega 3 and Vitamin D in Patients Undergoing Duodenopancreatectomy for Tumoral Lesion. (SIO3D)

Pancreatic Cancer | Surgery | Complication,Postoperative

Belgium
University Hospital, Ghent

Completed

Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT) (IMPRINT)

Prostatic Neoplasms | Prostate Cancer | Prostate Adenocarcinoma

Belgium
University Hospital, Ghent
Jessa Hospital; University Hospital, Antwerp; AZ Sint-Jan AV; AZ Delta; General Hospital... and other collaborators

Terminated

BLood Groups as Biomarker to Optimize Odds of Response to Anti-PD-1 Drugs (BLOOD)

Melanoma | Cancer

Belgium
Hasselt University
Jessa Hospital

Completed

Laser Therapy for the Prevention of Radiodermatitis in Breast Cancer Patients (TRANSDERMIS)

Breast Cancer

Belgium
University Hospital, Ghent

Completed

EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer

Lung Cancer

Belgium
Sanofi

Completed

Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer (CILAB)

Urinary Bladder Neoplasms

Belgium, Mexico, Brazil, Chile, Poland, South Africa, Spain, Israel, United States, Argentina, Australia, Canada, France, India, Italy, Netherlands, Russian Federation, Sweden, Turkey
Rainier Therapeutics

Terminated

A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma (FIERCE-22)

Urinary Bladder Disease | Locally Advanced or Metastatic Urothelial Cell Carcinoma | Urological Diseases

United States, Spain, Belgium, France, Germany, Italy, Korea, Republic of, Turkey, Hungary, Netherlands, Serbia, Poland, Russian Federation, Sweden, Moldova, Republic of, Denmark, Ukraine
Hasselt University
Jessa Hospital

Recruiting

PBMT for the Management of CIA ( HAIRLASER )

Breast Cancer | Alopecia | Chemotherapy-induced Alopecia

Belgium
University Hospital, Gasthuisberg

Unknown

Circumferential Section Pane Less Than 1 mm in Esophagectomy for Esophageal Cancer.

Esophageal Cancer

Belgium
Niti Medical Technologies Ltd.
University Hospital, Gasthuisberg

Unknown

Compression Anastomosis For Low Anterior Resection in Previously Radiated Patients Using the CAR™ 27

Colorectal Cancer

Belgium
KU Leuven

Unknown

Monitoring and Telecoaching of Physical Activity in Patients With Stage III and IV Non-small Cell Lung Cancer

Neoplasms | Exercise

Belgium
European Organisation for Research and Treatment...

Completed

Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx

Head and Neck Cancer

Belgium
University of Liege
Centre Hospitalier Universitaire de Liege; Bial Foundation; FNRS (Télévie); Fondation...

Recruiting

Cognitive Trance, Hypnosis and Meditation in Oncology

Pain | Cancer | Fatigue | Cognitive Impairment | Sleep Disturbance | Distress, Emotional

Belgium
Hasselt University
Jessa Hospital; University Hospital, Ghent; University Ghent

Recruiting

Investigating the Feasibility of a Physical Activity (Tele)Coaching Intervention in Patients With Non-small Cell Lung Cancer: an Explorative Study (LUCA-coach)

Non-small Cell Lung Cancer | Non-small Cell Carcinoma

Belgium
AstraZeneca

Completed

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel

Advanced Ovarian Cancer | Paclitaxel | Carboplatin | Triple Negative Metastatic Breast Cancer

Belgium, Netherlands, United Kingdom
Novigenix SA

Completed

Relapse Markers for Colorectal Cancer (RELMA-C)

Colorectal Cancer

Belgium
Hasselt University
Ziekenhuis Oost-Limburg

Completed

Colorectal Cancer Detected by 1H-NMR Spectroscopy (BIOCOR)

Colorectal Cancer

Belgium
DNAlytics

Unknown

Peripheral Blood Monocytes as Predictive Marker for Colorectal Cancer Diagnosis: A Comparative Study of a Stool Based Versus Blood Based Screening Test (MonoFIT+)

Colorectal Cancer

Belgium
University Hospital, Ghent

Completed

Use of 18F-PSMA-11 PET for Detection of Lesions in Iodine Refractory Thyroid Cancers

Thyroid Cancer

Belgium
Genmab

Terminated

Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer (GEN206)

Colorectal Cancer

Belgium
University Hospital, Ghent

Completed

PSMA-PET/CT for Prostate Cancer (NGP1)

Prostate Cancer

Belgium
Novosanis NV
Universiteit Antwerpen

Recruiting

Investigation of Urinary Biomarkers for the Detection of Breast Cancer (URODETECT-WP3)

Breast Cancer | Urine | Liquid Biopsy

Belgium
University Hospital, Antwerp
Universiteit Antwerpen

Completed

Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES) (SYRINGES)

Non-Small Cell Lung Cancer

Belgium
Pfizer

Terminated

Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer

Early Breast Cancer (Phase 2) | Advanced Breast Cancer (Phase 1b)

Spain, Sweden, Italy, Belgium
Universitair Ziekenhuis Brussel

Recruiting

Clinical Trial of SBRT and Systemic Pembrolizumab With or Without Avelumab/Ipilimumab+ Dendritic Cells in Solid Tumors (Luscid)

Solid Tumor | Non Small Cell Lung Cancer

Belgium
AZ Sint-Jan AV

Recruiting

Prospective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw Reconstruction (O-BRIDGE)

Head and Neck Cancer | Osteonecrosis | Osteoradionecrosis

Belgium
University Hospital, Ghent
University Ghent

Recruiting

GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy. (GRACE)

Breast Cancer | Vulvovaginal Atrophy

Belgium
University of Liege

Unknown

Oral Care Study of Postoperative Infections

Cancer, Mouth

Belgium
EMD Serono

Terminated

MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)

Metastatic Colorectal Cancer

Italy, Spain, Belgium
European Organisation for Research and Treatment...
Merck KGaA, Darmstadt, Germany

Terminated

Colorectal Cancer (CRC) Cetuximab Elderly Frail

Colorectal Cancer Metastatic

Cyprus, Belgium, Spain
Universiteit Antwerpen
Universitaire Ziekenhuizen KU Leuven; KU Leuven; University Hospital, Antwerp; University...

Recruiting

Effectiveness of an eHealth Self-management Support Program for Persistent Pain After Breast Cancer Treatment (PECAN)

Breast Cancer

Belgium
University Hospital, Ghent

Enrolling by invitation

Validation of the Global Polypectomy Assessment Tool (GPAT) (GPAT)

Colo-rectal Cancer | Colorectal Adenoma | Colorectal Polyp

Belgium
Aquinox Pharmaceuticals (Canada) Inc.

Unknown

Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome (LEADERSHIP 301)

Interstitial Cystitis | Painful Bladder Syndrome | Bladder Pain Syndrome | Chronic Interstitial Cystitis

United States, Belgium, Canada, Czechia, Denmark, Hungary, Latvia, Netherlands, Poland, Romania, Spain, United Kingdom
Maastricht Radiation Oncology
Universitaire Ziekenhuizen KU Leuven

Completed

Detection of Circulating Biomarkers of Immunogenic Cell Death (ICD)

Non Small Cell Lung Cancer

Netherlands, Belgium
Jules Bordet Institute

Completed

Indocyanine Green (ICG) in the ex Vivo Detection of Sentinel Lymph Node (SLN)in Colon Cancer (2068)

Colon Cancer | Colon Surgery

Belgium
University Hospital, Ghent
Farmafyt

Completed

Evaluation of the Efficacy and Safety of Common Sage in Controlling Hot Flashes in Prostate Cancer Patients Treated by Androgen Deprivation

Prostate Cancer

Belgium
University Hospital, Ghent

Completed

The Impact of Remote Training on Colonoscopy KPIs

Colorectal Cancer | Training | Colonoscopy

Belgium
General Hospital Groeninge

Completed

Validation of uHear™ as a Screening Tool to Detect Hearing Impairment in Elderly Cancer Patients Within a Comprehensive Geriatric Assessment (UHEAR)

Cancer | Hearing Loss

Belgium
Cliniques universitaires Saint-Luc- Université...
Merck Sharp & Dohme LLC

Completed

Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study (ECHO)

Time to Progression

Belgium
University Hospital, Ghent

Recruiting

ARTIficial Intelligence-based Smartphone Application for Skin Cancer Detection (ARTIS)

Skin Cancer

Belgium
General Hospital Groeninge

Completed

Validation of uHear™ as a Screening Tool to Detect Hearing Impairment in Older Cancer Patients Within a Comprehensive Geriatric Assessment - BIS (UHEAR-BIS)

Older Cancer Patients

Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Assessment of Adherence and Efficiency of a Home-based Training Program on Muscular Strength, Endurance and Qol for Colon Cancer Patients

Colon Cancer

Belgium
Jules Bordet Institute

Unknown

Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia (PAPALDO)

Breast Cancer

Belgium
University Medical Center Groningen

Recruiting

Cardiopulmonary Toxicity of Thoracic Radiotherapy (CLARIFY)

Non Small Cell Lung Cancer | Oesophageal Cancer

Belgium, Netherlands, United Kingdom
Merck KGaA, Darmstadt, Germany

Completed

AS703569 and Gemcitabine Combination in Advanced Malignancies

Pancreatic Cancer

Belgium, France
Incyte Corporation

Completed

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

Hepatocellular Carcinoma | Colorectal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Bladder Cancer | Triple Negative Breast Cancer | Pancreatic Ductal Adenocarcinoma | Castration Resistant Prostate Cancer | Gastric/ Gastroesophageal Junction | Squamous Carcinoma...

United States, Spain, France, United Kingdom, Italy, Belgium
Jules Bordet Institute

Withdrawn

Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer (RHEA)

Breast Cancer

Belgium, France
University Ghent
University Hospital, Ghent; Kom Op Tegen Kanker

Recruiting

Minimally INvasive Colon Cancer Surgery Through IMmunomics and Optical Mapping of the Sentinel Lymph Node. (MINIMAL)

Colon Cancer | Sentinel Lymph Node

Belgium
University Hospital, Antwerp
Eli Lilly and Company; Universiteit Antwerpen

Completed

Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (PACCORA)

Non-Small Cell Lung Cancer

Belgium

Clinical Trials on Bladder Cancer Recurrent in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations